Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Carlos Salama discusses how hospitalized patients with Covid-19 pneumonia who were not receiving mechanical ventilation and received tocilizumab showed a reduction in the likelihood of progression to the composite outcome of mechanical ventilation or death, but it did not improve survival.

Image courtesy of Carlos Salama

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

×
As a Guest, you have insight(s) remaining for this month. Create a free account to view 300 more annually.
Related Posts
error: Faculti Content is protected. Please check our Privacy Policy and Terms and Conditions.

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×